Descovy

DRUG6 trials

Sponsors

Technical University of Munich, Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia, Vivent Health, HQ Toronto, King's College Hospital NHS Trust

Conditions

Chronic Kidney DieaseHIV PreventionHIV-1-infectionHIV-InfectionKidney FailurePharmacokineticsTenofovirTenofovir Alafenamide Fumarate

Phase 2

Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals

CompletedNCT04097925

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaHIV-1-infection

Start: 2020-02-18End: 2020-08-24Updated: 2022-07-06

Phase 3

Dual Therapy With Boosted Darunavir + Dolutegravir

CompletedNCT02486133

Technical University of MunichHIV-Infection

Start: 2015-07-31End: 2018-05-31Updated: 2023-11-29

Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals

CompletedNCT04079452

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaHIV-1-infection

Start: 2020-02-18End: 2020-08-31Updated: 2022-04-28

Phase 4

Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: e-PrEP

CompletedNCT05528653

Vivent HealthHIV Prevention

Start: 2022-07-19End: 2025-03-21Updated: 2025-09-23

Unknown Phase

Express Testing and Same-day Initiation of PrEP Study

Active, not recruitingNCT05690815

HQ TorontoHIV Prevention

Start: 2023-01-24End: 2024-11-30Target: 816Updated: 2024-03-29

Tenofovir Exposures in Advanced Kidney Disease Study

Not yet recruitingNCT07812571

King's College Hospital NHS TrustChronic Kidney Diease, Kidney Failure, Pharmacokinetics +2

Start: 2026-11-01End: 2027-12-31Target: 50Updated: 2026-09-10